Amount Raised
$3.5 Million
Round Type
Seed
New YorkOtherBiotechnologySoftwareHealth CareDescription
When COVID-19 closed down most of society in 2020, Kian Sadeghi, like many of his then-classmates at the University of Pennsylvania, found himself holed up in his bedroom. He prefers it that way.
Who else raised in Biotechnology and Software around the same time
Companies in the same sectors as Nucleus Genomics that raised within 45 days of this round, from Fundz verified event records.
- ITERATIVE SCOPES, INC. raised $150M (Series B) on January 19, 2022.
- Tasso raised $100M (Series B) on December 16, 2021.
- ITERATIVE SCOPES, INC. raised $140M on December 14, 2021.
- Stilla Technologies raised an undisclosed amount on November 23, 2021.
- RedHill Biopharma Ltd raised $5M on November 22, 2021.
- DeepCure raised $40M (Series A) on November 8, 2021.
Who to call at Nucleus Genomics, and when
A new round usually means Nucleus Genomics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nucleus Genomics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nucleus Genomics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nucleus Genomics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nucleus Genomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nucleus Genomics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.